初治肺癌的先天遗传演化与空间异质性分析
该研究对5例初治肺癌患者的30份原发灶、胸腔内及胸腔外转移灶标本行RNA测序,分析治疗前肿瘤间异质性。无监督聚类显示病灶按患者聚类而非按转移部位,原发灶与转移灶存在异质性,转移灶中细胞增殖通路上调、免疫相关通路下调。
要点
- 初治肺癌原发灶与转移灶间存在肿瘤间异质性。
- 转移灶细胞增殖通路上调,免疫相关通路下调。
- 转移灶能否替代原发灶用于生物标志物检测需谨慎评估。
核心结论
- 初治肺癌原发灶与转移灶间存在异质性,转移灶不能简单替代原发灶用于生物标志物指导治疗。
研究设计与样本
- 对5例初治肺癌患者的30份标本(原发灶、胸腔内转移灶、胸腔外转移灶)行RNA测序分析肿瘤间异质性。
主要发现
- 全局无监督聚类显示病灶按个体患者聚类,而非按转移部位聚类。
- 突变与转录数据提示原发灶通常不同于转移灶,存在肿瘤间异质性。
- 转移灶中细胞增殖相关通路上调,免疫相关通路下调。
临床怎么用
- 基于转移灶的生物标志物结果解读需结合原发灶信息,避免简单替代。
- 治疗决策中应考虑原发灶与转移灶间的空间异质性。
局限性
- 样本量小(5例患者、30份标本),结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Data regarding the pre-treatment intertumor heterogeneity of potential biomarkers in advanced-stage lung cancers is limited. A finding of such heterogeneity between primary and metastatic lesions would prove valuable to determine if a metastatic lesion can be a surrogate for the primary tumor, as more biomarkers will likely be used in the future to inform treatment decisions. METHODS: We performed RNA sequencing to analyze intertumor heterogeneity in 30 specimens (primary tumors, intrathoracic, and extrathoracic metastatic lesions) obtained from five treatment-naïve lung cancer patients. RESULTS: The global unsupervised clustering analysis showed that the lesions clustered at the individual patient level rather than on the metastatic sites, suggesting that the characteristics of specific tumor cells have a greater impact on the gene expression signature than the microenvironment in which the metastasis develops. The mutational and transcriptional data highlight the presence of intertumor heterogeneity showing that the primary tumors are usually distinct from metastatic lesions. Through a comparison between metastatic lesions and the primary tumors, we observed that pathways related to cell proliferation were upregulated, whereas immune-related pathways were downregulated in metastatic lesions. CONCLUSION: These data not only provide insight into the evolution of lung cancers, but also imply possibilities and limitations of biomarker-based treatment in lung cancers.
引用
- Suda K, Kim J, Murakami I, et al. Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve Lesions. J Thorac Oncol. 2018. PMID: 29933065. doi:10.1016/j.jtho.2018.05.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。